Icosapent Ethyl

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 67184-0582
  • Package NDC 67184-0582-1
  • Application number ANDA218899
  • SPL ID 324fd508-befc-404a-8f75-97b35d2df694
  • SPL set ID 20686acb-66c5-4d75-9684-7474436e8bef
  • UNII 6GC8A4PAYH
  • RxCUI 1304979

What the source publishes

Labeler
Qilu Pharmaceutical Co., Ltd.
Active ingredients
Icosapent Ethyl
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:67184-0582_324fd508-befc-404a-8f75-97b35d2df694
{
  "name": "Icosapent Ethyl",
  "splId": "324fd508-befc-404a-8f75-97b35d2df694",
  "labels": [
    {
      "setId": "20686acb-66c5-4d75-9684-7474436e8bef",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=20686acb-66c5-4d75-9684-7474436e8bef",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=20686acb-66c5-4d75-9684-7474436e8bef"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Qilu Pharmaceutical Co., Ltd.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "120 CAPSULE in 1 BOTTLE (67184-0582-1)",
      "package_ndc": "67184-0582-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250101"
    }
  ],
  "productId": "67184-0582_324fd508-befc-404a-8f75-97b35d2df694",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "67184-0582",
  "deaSchedule": null,
  "genericName": "Icosapent Ethyl",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ICOSAPENT ETHYL",
      "strength": "1 g/1"
    }
  ],
  "applicationNumber": "ANDA218899",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250101",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "6GC8A4PAYH"
    ],
    "rxcui": [
      "1304979"
    ],
    "spl_set_id": [
      "20686acb-66c5-4d75-9684-7474436e8bef"
    ],
    "manufacturer_name": [
      "Qilu Pharmaceutical Co., Ltd."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:67184-0582_324fd508-befc-404a-8f75-97b35d2df694"